Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery

The present study deals with the development of transferosomal gel containing insulin by reverse phase evaporation method for painless insulin delivery for use in the treatment of insulin dependent diabetes mellitus. The effect of independent process variables like ratio of lipids (soya lecithin:cho...

Full description

Saved in:
Bibliographic Details
Published inSaudi pharmaceutical journal Vol. 20; no. 4; pp. 355 - 363
Main Authors Malakar, Jadupati, Sen, Suma Oomen, Nayak, Amit Kumar, Sen, Kalyan Kumar
Format Journal Article
LanguageEnglish
Published Saudi Arabia Elsevier B.V 01.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present study deals with the development of transferosomal gel containing insulin by reverse phase evaporation method for painless insulin delivery for use in the treatment of insulin dependent diabetes mellitus. The effect of independent process variables like ratio of lipids (soya lecithin:cholesterol), ratio of lipids and surfactants, and ratio of surfactants (Tween 80:sodium deoxycholate) on the in vitro permeation flux (μg/cm2/h) of formulated transferosomal gels containing insulin through porcine ear skin was optimized using 23 factorial design. The optimal permeation flux was achieved as 13.50±0.22μg/cm2/h with drug entrapment efficiency of 56.55±0.37% and average vesicle diameter range, 625–815nm. The in vitro insulin permeation through porcine ear skin from these transferosomal gel followed zero-order kinetics (R2=0.9232–0.9989) over a period of 24h with case-II transport mechanism. The in vitro skin permeation of insulin from optimized transferosomal gel by iontophoretic influence (with 0.5mA/cm2 current supply) also provided further enhancement of permeation flux to 17.60±0.03μg/cm2/h. The in vivo study of optimized transferosomal gel in alloxan-induced diabetic rat has demonstrated prolonged hypoglycemic effect in diabetic rats over 24h after transdermal administration.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1319-0164
2213-7475
DOI:10.1016/j.jsps.2012.02.001